Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family

Arenaviral infections often result lethal hemorrhagic fevers, affecting primarily in African and South American regions. To date, there is no FDA-approved licensed vaccine against arenaviruses and treatments have been limited to supportive therapy. Hence, the study was employed to design a highly im...

Descripción completa

Detalles Bibliográficos
Autores principales: Azim, Kazi Faizul, Lasker, Tahera, Akter, Rahima, Hia, Mantasha Mahmud, Bhuiyan, Omar Faruk, Hasan, Mahmudul, Hossain, Md Nazmul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144012/
https://www.ncbi.nlm.nih.gov/pubmed/34041391
http://dx.doi.org/10.1016/j.heliyon.2021.e07022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144012/
https://www.ncbi.nlm.nih.gov/pubmed/34041391
http://dx.doi.org/10.1016/j.heliyon.2021.e07022

Ejemplares similares